| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | -64.0% |
| R&D Expense | $62.0M | -37.0% |
| SG&A Expense | $31.3M | -18.0% |
| Operating Income | -$101.4M | +23.9% |
| Pre-tax Income | -$87.1M | -7368.8% |
| Income Tax | $0 | -100.0% |
| Net Income | -$113.0M | -2157.0% |
| EPS (Basic) | -$1.95 | -2066.7% |
| EPS (Diluted) | -$1.95 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.3M | +15.5% |
| Current Assets | $83.9M | -53.6% |
| Total Assets | $84.6M | -63.0% |
| Current Liabilities | $11.6M | -48.7% |
| Total Liabilities | $11.6M | -77.1% |
| Stockholders' Equity | $73.0M | -59.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$96.2M | +15.3% |
| Capital Expenditures | $228K | -82.3% |
| Investing Cash Flow | $101.3M | +176.0% |
| Financing Cash Flow | $184K | -69.1% |
| Free Cash Flow | -$96.5M | +16.1% |
| -2066.7% |